EUVIMEDEUVIMED entdecken
Crossref

0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa

A. Young, X. Zhan, J. Labrador Pino, K. Scott, R. Djemil, L. Bradford, R. Raut, Q. Mi

Journal of Investigative Dermatology · 2026-08 · 146 (8) · S47

DOI: 10.1016/j.jid.2026.06.301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von A. Young und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Young, A., Zhan, X., Pino, J. L., Scott, K., Djemil, R., Bradford, L., Raut, R., & Mi, Q. (2026). 0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa. Journal of Investigative Dermatology, 146(8), S47. https://doi.org/10.1016/j.jid.2026.06.301

Vancouver

Young A, Zhan X, Pino JL, Scott K, Djemil R, Bradford L, et al. 0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa. Journal of Investigative Dermatology. 2026;146(8):S47. doi:10.1016/j.jid.2026.06.301

BibTeX
@article{Young2026,
  author = {Young, A. and Zhan, X. and Pino, J. Labrador and Scott, K. and Djemil, R. and Bradford, L. and Raut, R. and Mi, Q.},
  title = {0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  volume = {146},
  number = {8},
  pages = {S47},
  doi = {10.1016/j.jid.2026.06.301}
}
Kostenlos starten →